Prediabetes remission to reduce the global burden of type 2 diabetes

Leontine Sandforth, Stephanie Kullmann, Arvid Sandforth, Andreas Fritsche, Reiner Jumpertz-von Schwartzenberg, Norbert Stefan, Andreas L. Birkenfeld*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Prediabetes is a highly prevalent and increasingly common condition affecting a significant proportion of the global population. The heterogeneous nature of prediabetes presents a challenge in identifying individuals who particularly benefit from lifestyle or other therapeutic interventions aiming at preventing type 2 diabetes (T2D) and associated comorbidities. The phenotypic characteristics of individuals at risk for diabetes are associated with both specific risk profiles for progression and a differential potential to facilitate prediabetes remission and reduce the risk of future T2D. This review examines the current definition and global prevalence of prediabetes and evaluates the potential of prediabetes remission to reduce the alarming increase in the global burden of T2D.

Original languageEnglish
JournalTRENDS IN ENDOCRINOLOGY AND METABOLISM
DOIs
Publication statusAccepted/In press - 2025

Keywords

  • normal glucose tolerance
  • obesity
  • prediabetes
  • remission
  • type 2 diabetes

Fingerprint

Dive into the research topics of 'Prediabetes remission to reduce the global burden of type 2 diabetes'. Together they form a unique fingerprint.

Cite this